💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueLearn More

Lonza Group AG (LONNE)

Switzerland
Currency in CHF
Disclaimer
543.80
+6.40(+1.19%)
Closed
LONNE Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
Day's Range
540.40546.00
52 wk Range
309.60589.00
Bid/Ask
543.80 / 590.00
Prev. Close
537.4
Open
540.4
Day's Range
540.4-546
52 wk Range
309.6-589
Volume
3,700
Average Vol. (3m)
3,838
1-Year Change
10.53%
Fair Value
Unlock
Fair Value Upside
Unlock
LONNE Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
623.67
Upside
+14.69%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Lonza Group AG Company Profile

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing. The Small Molecules segment operates as an integrated development and manufacturing service provider for small molecule drug substances and their intermediates. This segment also supports customers across various aspects of design, development, and manufacturing, including particle engineering and drug product packaging. The Cell & Gene segment develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies; offers contract development and manufacturing services, and regulatory support for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. This segment also provides Cocoon platform, a closed automated system for patient-scale cell therapy manufacturing; and specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. The Capsules & Health Ingredients segment offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.

Compare LONNE to Peers and Sector

Metrics to compare
LONNE
Peers
Sector
Relationship
P/E Ratio
67.6x19.3x−0.6x
PEG Ratio
−1.40−0.280.00
Price / Book
4.1x2.6x2.6x
Price / LTM Sales
5.8x3.6x3.1x
Upside (Analyst Target)
17.4%23.5%58.3%
Fair Value Upside
Unlock4.2%8.8%Unlock

FAQ

What Is the Lonza (LONNE) Stock Price Today?

The Lonza stock price today is 543.80

What Stock Exchange Does Lonza Trade On?

Lonza is listed and trades on the Switzerland stock exchange.

What Is the Stock Symbol for Lonza?

The stock symbol for Lonza is "LONNE."

Does Lonza Pay Dividends? What’s The Current Dividend Yield?

The dividend yield is 0.37%.

What Is the Lonza Market Cap?

As of today, Lonza market cap is 39.22B.

What is Lonza Earnings Per Share?

The Lonza EPS is 7.92.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.